View in EDS

Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma.

Saved in:
Bibliographic Details
Title: Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma.
Authors: Sanikommu S; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA. vms136@miami.edu., Santos AN; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA., Dawoud B; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA., Shah KH; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA., Vazquez S; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA., Shah AH; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA., Lu VM; Department of Neurosurgery, Miller School of Medicine, University of Miami, 1501 NW 10th Avenue, 832 G, Miami, FL, 33136, USA.
Source: Targeted oncology [Target Oncol] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01225-0